Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first2,601 to 2,620 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| RIEG2 Rieger syndrome 2 | 6012 | 0 | 0 | 0 | 0 | 1,170 | 2,400 |
| MSMB microseminoprotein beta | 4477 HGNC:7372 | 1 | 53 | 0 | 0 | 1,170 | 2,399 |
| CCL27 C-C motif chemokine ligand 27 | 10850 HGNC:10626 | 1 | 91 | 0 | 0 | 1,344 | 2,398 |
| MLST8 MTOR associated protein MLST8 | 64223 HGNC:24825 | 1 | 41 | 1 | 11 | 1,779 | 2,397 |
| PPM1D protein phosphatase, Mg2+/Mn2+ dependent 1D | 8493 HGNC:9277 | 1 | 32 | 0 | 0 | 1,526 | 2,396 |
| SRA1 steroid receptor RNA activator 1 | 10011 HGNC:11281 | 1 | 0 | 0 | 0 | 1,452 | 2,396 |
| IRF2 interferon regulatory factor 2 | 3660 HGNC:6117 | 1 | 39 | 0 | 0 | 1,791 | 2,395 |
| MLLT3 MLLT3 super elongation complex subunit | 4300 HGNC:7136 | 1 | 19 | 0 | 0 | 1,646 | 2,395 |
| ARID2 AT-rich interaction domain 2 | 196528 HGNC:18037 | 1 | 29 | 0 | 0 | 1,580 | 2,393 |
| FCGR3B Fc gamma receptor IIIb | 2215 HGNC:3620 | 1 | 62 | 0 | 0 | 1,380 | 2,393 |
| MIR152 microRNA 152 | 406943 HGNC:31538 | 0 | 0 | 0 | 0 | 641 | 2,393 |
| MX2 MX dynamin like GTPase 2 | 4600 HGNC:7533 | 1 | 43 | 0 | 0 | 1,681 | 2,393 |
| KIR2DL3 killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3 | 3804 HGNC:6331 | 1 | 84 | 2 | 14 | 1,324 | 2,392 |
| MIR326 microRNA 326 | 442900 HGNC:31769 | 0 | 0 | 0 | 0 | 526 | 2,392 |
| CAPN1 calpain 1 | 823 HGNC:1476 | 1 | 124 | 0 | 0 | 1,390 | 2,391 |
| MIR130B microRNA 130b | 406920 HGNC:31515 | 0 | 0 | 0 | 0 | 806 | 2,391 |
| RFC1 replication factor C subunit 1 | 5981 HGNC:9969 | 1 | 24 | 0 | 0 | 1,549 | 2,391 |
| GGTLC4P gamma-glutamyltransferase light chain 4 pseudogene | 729838 HGNC:33428 | 0 | 0 | 0 | 0 | 677 | 2,390 |
| KIF5B kinesin family member 5B | 3799 HGNC:6324 | 1 | 56 | 2 | 28 | 1,449 | 2,390 |
| MIR34B microRNA 34b | 407041 HGNC:31636 | 0 | 0 | 0 | 0 | 839 | 2,389 |
Code
curl "https://conductscience.org/api/genes/v1?page=131"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=131
{
"data": {
"total": 193990,
"results": [
{
"id": "6012",
"title": "RIEG2: Rieger syndrome 2",
"summary": "NCBI Gene 6012. 0 proteins, 0 patents, 0 drugs, 0 trials, 1,170 NIH grants and 2,400 papers.",
"record": "/library/genes/6012",
"gene_id": 6012,
"symbol": "RIEG2",
"name": "Rieger syndrome 2",
"hgnc_id": null,
"counts": {
"proteins": 0,
"patents": 0,
"drugs": 0,
"trials": 0,
"grants": 1170,
"papers": 2400
}
},
{
"id": "4477",
"title": "MSMB: microseminoprotein beta",
"summary": "NCBI Gene 4477. 1 protein, 53 patents, 0 drugs, 0 trials, 1,170 NIH grants and 2,399 papers.",
"record": "/library/genes/4477",
"gene_id": 4477,
"symbol": "MSMB",
"name": "microseminoprotein beta",
"hgnc_id": "HGNC:7372",
"counts": {
"proteins": 1,
"patents": 53,
"drugs": 0,
"trials": 0,
"grants": 1170,
"papers": 2399
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=132",
"request_id": "oRGf47fN3Z-cyr2H"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant